Related Experiment Video
Updated: Mar 7, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Preterm births and use of medication in early adulthood: a population-based registry study
Anders Engeland1,2, Tone Bjørge2,3, Kari Klungsøyr2,4
1Department of Pharmacoepidemiology, Norwegian Institute of Public Health, Bergen/Oslo, Norway.
Purpose:
To explore associations between preterm birth and use of medications in young adulthood as a proxy for different diseases.
Methods:
We linked data on birth characteristics from the Medical Birth Registry of Norway (1967-1999) and the Norwegian Prescription Database (2004-2015). Individuals born as singletons during 1974-1984 and alive at the age of 31 were included (main analyses) (n = 450 555). Relative risks (RRs) with 95% confidence intervals (CIs) of using different medications were estimated by log-binomial regression. Population attributable risk and attributable risk percentage (PAR% and AR%) due to preterm birth were calculated.
Results:
Individuals born preterm used more specific medications at age 30 than those born at term. The risks of being dispensed psychotropic medications overall and the subgroups antiepileptics, antipsychotics, anxiolytics and hypnotics were elevated in individuals born preterm. For attention-deficit/hyperactivity disorder medications, the risk was elevated in males born extremely preterm (RR 5.8; 95%CI: 2.2-15). The risk of being dispensed antiasthmatics increased by shorter gestational ages. For psychotropic medications, PAR% was 0.6% in males and 0.7% in females at age 30; AR% was 13% in males and 17% in females. For antiasthmatics, the corresponding figures were 1.4, 1.1, 24 and 23%.
Conclusion:
Individuals born preterm used more psychotropic medications overall and antiasthmatics around age 30 than those born at term. The proportions using these medications increased for those born at earlier gestational ages. Those born preterm, especially before 32 weeks of gestation, should be given special attention during early adulthood regarding development of symptoms and signs of certain diseases. Copyright © 2017 John Wiley & Sons, Ltd.
More Related Videos
10:02Event Related Potentials ERPs and other EEG Based Methods for Extracting Biomarkers of Brain Dysfunction: Examples from Pediatric Attention Deficit/Hyperactivity Disorder ADHD
Published on: March 12, 2020
05:13Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Related Concept Videos
Factors Affecting Drug Response: Overview
Regression Toward the Mean
Drug Toxicity: Risk factors
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drug Dosing: Geriatric Patients